Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTGS1 | P23219 | 1/20 | 0.48 |
| ▸ | KDR | P35968 | 1/20 | 0.32 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.30 |
| ▸ | AKR1C3 | P42330 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11132623 | 0.83 | PTGS1 (0.45) | PTGS1KDR | |
| SCHEMBL111264 | 0.79 | PTGS1 (0.50) | PTGS1KDRTDP1AKR1C3 | |
| SCHEMBL16129662 | 0.79 | PTGS1 (0.50) | PTGS1KDRTDP1AKR1C3 | |
| SCHEMBL346616 | 0.77 | PTGS1 (0.71) | PTGS1TDP1AKR1C3 | |
| SCHEMBL11131678 | 0.76 | PTGS1 (0.47) | PTGS1 | |
| SCHEMBL2223057 | 0.76 | PTGS1 (0.47) | PTGS1KDR | |
| SCHEMBL2506496 | 0.76 | PTGS1 (0.47) | PTGS1 | |
| SCHEMBL2243778 | 0.75 | — | — | |
| SCHEMBL475079 | 0.75 | — | — | |
| SCHEMBL28176299 | 0.75 | PTGS1 (0.68) | PTGS1TDP1AKR1C3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9303003-B2 | Process for producing glycidyl (meth)acrylate | MITSUBISHI RAYON CO., LTD. (JP) | 2016-04-05 | — | — | US | disclosed |
| US-20150291544-A1 | PROCESS FOR PRODUCING GLYCIDYL (METH)ACRYLATE | MITSUBISHI RAYON CO., LTD. (JP) | 2015-10-15 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150291544-A1 | PROCESS FOR PRODUCING GLYCIDYL (METH)ACRYLATE | TET2, ACR, ABL1 | PTGS1 1455/4885KDR 1404/4885TDP1 3496/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.